FdaApplication
NDA 022500
Identifiers
- fda_app_no: NDA022500
Properties
| Property | Value |
|---|---|
| applicant_name | ROSEMONT PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2009-12-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXICLON XR | CLONIDINE | EQ 0.17MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| NEXICLON XR | CLONIDINE | EQ 0.26MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products